LAS106521

DRUG2 trials

Sponsors

Almirall, S.A.

Conditions

Actinic Keratosis

Phase 2

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

CompletedNCT00991861

Almirall, S.A.Actinic Keratosis

Start: 2009-08-31End: 2010-02-28Target: 100Updated: 2015-05-29

Phase 3

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

CompletedNCT00987246

Almirall, S.A.Actinic Keratosis

Start: 2008-06-30End: 2009-06-30Updated: 2015-07-28